This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

When Must I Buy a Stock to Get the Dividend?

Stocks in this article: PFE

NEW YORK (TheStreet) -- The one question I hear most often about dividends is when do I have to buy a stock in order to receive the payment?

The answer is more complicated than you would think. The company doesn't tell you this date when the dividend is announced and it's not published on the quote pages of TheStreet.com, Yahoo Finance or even the expensive Bloomberg terminal on my desk.

That is, until I coined the term "must-own date" over a decade ago. Terms like "record date" and "ex-date" are commonly thrown around in dividend parlance, but the must-own date is the simple answer that most folks want to drill down to.

Here's how to determine the must-own date for any dividend, so you'll never be confused by this important question again.

First, when most dividends are announced, the company generally says it is "payable to shareholders of record" on a certain date. This is useful information, but investors often confuse the record date as the cutoff to receive the dividend.

The difference is that stock trades actually settle three days after the fact, even if you're a frequent trader that buys and sells the same name several times a day. Similarly, the ex-date is two trading days before the record date, so another way to look at the must-own date is the day before a stock goes ex-dividend.

So now that we know to subtract three days from the record date in order to determine the must-own date, how do the dynamics of the dividend actually work?

Here's an example: Pfizer (PFE) - which is a holding in the model portfolio of our Dividend Stock Advisor newsletter- increased its quarterly dividend earlier this month, to $0.28 a share (3.6% yield). The company will pay the dividend on March 3, 2015 to shareholders of record on Friday, Feb. 6, 2015.

Looking at the calendar, we can determine that the ex-date will be Wednesday, the 4th and the must-own date will be Tuesday, the 3rd. Again, only investors at the close of trading on Tuesday, the 3rd will receive the dividend.

You could have owned Pfizer for five years, but if you sell it on the must-own date, you will not receive the payment. On the other hand, it's possible to buy Pfizer shares in the final minutes of trading on Tuesday, the 3rd and receive the full dividend.

At the open of trading on the ex-date, Wednesday, the 4th, Pfizer shares will be adjusted 28 cents lower. This is to reflect the dividend being taken out of the stock, but there's no penalty because of the adjustment.

With that in mind, an investor can technically buy Pfizer at 3:59 p.m. ET on the 3rd and sell it at 9:31 a.m. ET on the 4th and still receive dividend in their account on March 3.

Dividends are an important part of investing for long-term growth, but the mechanics of how they're paid can be confusing for investors of any level. Check back here regularly to learn more about how dividends work and how they can be used to enhance overall returns.

-------------------------

Dividend investors, find dividend stock ideas in our dividend investor center. Also, don't forget to bookmark our list of high-dividend stocks and ex-dividend date calendar. New to dividend investing? Don't miss Dave's primer on how to invest in dividend stocks.

David Peltier is a research associate at TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks. He also doesn't invest in hedge funds or other private investment partnerships. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Peltier appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs